Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations    

Global ATC Market Research Report

PRODUCT TITLE PUBLISHED
Pinacidil Pinacidil
Pinacidil and its peer markets - Digital Pathology,
Upcoming
Alkaloids, excl. rauwolfia Alkaloids, excl. rauwolfia
Alkaloids, excl. rauwolfia and its peer markets - Digital Pathology,
Upcoming
Tyrosine hydroxylase inhibitors Tyrosine hydroxylase inhibitors
Tyrosine hydroxylase inhibitors and its peer markets - Wireless Health,
Upcoming
MAO inhibitors MAO inhibitors
MAO inhibitors and its peer markets - Serotonin antagonists,
Upcoming
Serotonin antagonists Serotonin antagonists
Serotonin antagonists and its peer markets - Proteomics,
Upcoming
Rauwolfia alkaloids and diuretics in combination Rauwolfia alkaloids and diuretics in combination
Rauwolfia alkaloids and diuretics in combination and its peer markets - Proteomics,
Upcoming
Methyldopa and diuretics in combination Methyldopa and diuretics in combination
Methyldopa and diuretics in combination and its peer markets - Hydrazinophthalazine derivatives and diuretics,
Upcoming
Imidazoline receptor agonists in combination with diuretics Imidazoline receptor agonists in combination with diuretics
Imidazoline receptor agonists in combination with diuretics and its peer markets - Chromatography,
Upcoming
Alpha-adrenoreceptor antagonists and diuretics Alpha-adrenoreceptor antagonists and diuretics
Alpha-adrenoreceptor antagonists and diuretics and its peer markets - Imidazoline receptor agonists in combination with...
Upcoming
Guanidine derivatives and diuretics Guanidine derivatives and diuretics
Guanidine derivatives and diuretics and its peer markets - Chromatography Instruments,
Upcoming
Hydrazinophthalazine derivatives and diuretics Hydrazinophthalazine derivatives and diuretics
Hydrazinophthalazine derivatives and diuretics and its peer markets - E-Clinical Trial Solutions,
Upcoming
Alkaloids, excl. rauwolfia, in combination with diuretics Alkaloids, excl. rauwolfia, in combination with diuretics
Alkaloids, excl. rauwolfia, in combination with diuretics and its peer markets - Methyldopa and diuretics in combination,
Upcoming
MAO inhibitors and diuretics MAO inhibitors and diuretics
MAO inhibitors and diuretics and its peer markets - Chromatography,
Upcoming
Serotonin antagonists and diuretics Serotonin antagonists and diuretics
Serotonin antagonists and diuretics and its peer markets - Other antihypertensives and diuretics,
Upcoming
Thiazides, plain Thiazides, plain
Thiazides, plain and its peer markets - Immunoassay, E-Clinical...
Upcoming
Thiazides and potassium in combination Thiazides and potassium in combination
Thiazides and potassium in combination and its peer markets - Chromatography Instruments,
Upcoming
Thiazides, combinations with psycholeptics and/or analgesics Thiazides, combinations with psycholeptics and/or analgesics
Thiazides, combinations with psycholeptics and/or analgesics and its peer markets - Thiazides and potassium in combination,
Upcoming
Thiazides, combinations with other drugs Thiazides, combinations with other drugs
Thiazides, combinations with other drugs and its peer markets - Next Generation Sequencing (NGS),
Upcoming
Sulfonamides, plain Sulfonamides, plain
Sulfonamides, plain and its peer markets - Sulfonamides and potassium in combination,
Upcoming
Sulfonamides and potassium in combination Sulfonamides and potassium in combination
Sulfonamides and potassium in combination and its peer markets - E-Clinical Trial Solutions,
Upcoming
606 reports | Show
Connect With Us
US/CAN : +1-888-502-0539